PROCOMB trial ( ISRCTN@ ) was a randomized double-blinded , double-dummy multicenter study of @ patients between @ and @ years old , PSA@ng/ml , IPSS @ , prostate volume @ cc , Qmax @ml/sec , postvoid residual urine ( PVR ) < @ml .